MITF and neoplasm: Melanoma intra-tumor heterogeneity does not rely on the classical cancer stem cell (CSC) hypothesis but rather on a “phenotype switching” model, reminiscent of EMT, which is largely dependent on the expression level of the Microphthalmia-associated transcription factor MITF, the master regulator of melanocyte development [26].